BIDIN LS contains Brimonidine which are Antiglaucoma agents. These are sterile, preserved, aqueous solution works by reducing pressure within the eyeball. It is used to treat the conditions of glaucoma or ocular hypertension (pressure in the eye). Glaucoma is a condition which damages the optic nerve, the health of which is vital for good vision. It is often caused by an abnormally high pressure in your eye. Ocular hypertension is a condition where the pressure inside the eye is higher than normal. In this condition the front of the eye does not drain aqueous humor (fluid in the eye) properly which causes eye pressure to build up.
Brimonidine has an effective ocular hypotensive effect which occurs at two hours post instillation. It works by reducing aqueous humor (fluid in the eye) production and increasing outflow of aqueous humor (uveoscleral outflow) and thus lowers the eye pressure. This medicine can be used alone or in conjunction with another eye drop that reduces pressure in the eye. It is for external use only. Tell your doctor if you wear contact lenses, before using the medication. It is not recommended for children between the ages of 2 and 12 years of age. The common side effects are allergic reactions, eye irritation and blurred or abnormal vision.
BIDIN LS works by reducing pressure within the eyeball by decreasing the production of aqueous humour (fluid in the eye), thereby lowering the increased eye pressure.
Always use as instructed by your doctor. Check the label for directions before use.
Dizziness or drowsiness:
Get up and move around to feel awake, take small naps to edge off the sleepiness. Give your eyes a break to avoid fatigue and eat a healthy food to boost energy.
Feeling sick (nausea) or indigestion:
Stick to simple normal meals and do not eat rich or spicy foods.
Dry mouth:
Chew sugar free candies to stimulate the flow of saliva. Limit your caffeine intake.
BIDIN LS should be used with caution in pregnant women. Consult your doctor before using this medicine.
BIDIN LS is not recommended for use in breastfeeding women unless necessary. Discuss the risks and benefits with your doctor.
Do not drive or operate machinery while taking this medicine, since it may cause blurred, abnormal vision, drowsiness or fatigue.
Consumption of alcohol is not recommended during treatment with BIDIN LS.
BIDIN LS should be used with caution in patients suffering from active kidney diseases. Consult your doctor for advice.
BIDIN LS should be used with caution in patients suffering from liver function impairment or active liver diseases. Consult your doctor for advice.
Do not use if you are allergic (hypersensitive) to Brimonidine or any ingredients of this medicine.
BIDIN LS should be used with caution in patients suffering from active heart diseases. Consult your doctor for advice.
Tell your doctor if you had or have a condition such as:
Tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or the following:
Drug | : | Brimonidine |
Pharmacological Category | : | Alpha2 Agonist, Ophthalmic agent, Antiglaucoma |
Therapeutic Indication | : | Elevated intraocular pressure, Ocular redness |
Dosage Forms | : | Ophthalmic solution, Gel |
Store below 20-25°C and keep out of reach of children.
Does BIDIN LS cause pupil dilation?
No, it does not cause pupil dilation. If you experience night vision difficulty, halos and glare. Contact your doctor if you experience these symptoms.
Does BIDIN LS cause drowsiness?
Yes, it may cause drowsiness and fatigue which may impair the ability to drive or use machinery. It may also cause blurred or abnormal vision especially at night or in dim light.
How BIDIN LS works?
It works by reducing pressure within the eyeball by decreasing the production of aqueous humor (fluid in the eye), thereby lowering the increased eye pressure.
1. KD Tripathi MD. Drugs acting on ANS. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page - 154.
2. Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page - 297.
3. Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page - 144.
4. Louis B Cantor. Brimonidine in the treatment of glaucoma and ocular hypertension: Therapeutics and clinical risk management. Dec 2006; [Accessed Dec 3, 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936355/
5. McLaurin, Eugene, Cavet, Megan E, Gomes, Paul J, Ciolino, Joseph B. Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial: OVS optometry and vision sciences. March 2018, Vol – 95, Issue -3 [Accessed Dec 3, 2020] https://journals.lww.com/optvissci/fulltext/2018/03000/brimonidine_ophthalmic_solution_0_025__for.13.aspx
6. FDC International Ltd, Electronic Medicines Compendium (EMC); [Revised Oct 2020] [Accessed Dec 3, 2020] https://www.medicines.org.uk/emc/files/pil.3426.pdf
7. Allergan, 1996; U.S. Food & Drug Administration; [Accessed Dec 3, 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020613s031lbl.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.